UCB's Global Corporate Website
Welcome to UCB in the United States



Contributing to Environmental Sustainability this Earth Day and Every Day



UCB Community Health Fund Supports U.S. Organizations Addressing Mental Health and Young People

UCB recently announced the funding recipients for the UCB Community Health Fund’s 2021 call for projects, focused on the needs of vulnerable young people in the wake of COVID-19. Three U.S.-based organizations will receive support from the Fund for projects addressing the mental health of vulnerable young people. 




Advancing Our Mission to Cure Epilepsy

With nearly 30 years of experience in epilepsy, UCB can and will unlock what's possible for the millions of people living with epilepsy, so their reality can be free from seizures and the other debilitating and unpredictable impacts of the disease. Hear from Mike Davis, Head of U.S. Neurology and Rare, share our plan to impact the underlying causes of the disease and to discover, develop, and deliver highly differentiated medicines that will transform and, ultimately, cure the disease, so that people living with epilepsy can live their ideal life, every day.



UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting



FINTEPLA® (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)



New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting



UCB at the 2022 AAD Annual Meeting: Our Commitment to Advancing Science in Dermatology





North Carolina Academic Engagement Night - Investing in our Future through STEM

At UCB, we are committed to accelerating scientific discoveries by supporting innovation ultimately leading to the discovery of new solutions to help people capture the moments that matter. Part of this commitment is a strong foundational support for STEM education in our communities to help inspire the next generation of scientists.



Voices on Value: Building a Sustainable Healthcare System Together – Our U.S. Sustainable Access and Pricing Transparency Report

Last year, UCB launched its Voices on Value blog series to foster a dialogue around how to make our health system better, stronger, and more accessible now and in the future. To advance this dialogue, UCB is releasing its first-ever U.S. Sustainable Access and Pricing Transparency Report, which underscores UCB’s commitment to an innovative, competitive, and value-based system. 



UCB Completes Acquisition of Zogenix, Inc.